» Articles » PMID: 28994522

[Moderation-integrated-balance Presupposition of Chinese Medicine Compound and Pharmacological Problems in Traditional Chinese Drug Research]

Overview
Date 2017 Oct 11
PMID 28994522
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The moderation-integrated-balance presupposition (MIBP) of Chinese medicine compound was first proposed in this paper based on the review of function characteristics and action principles of Chinese medicine compound. Furthermore, the pharmacological problems of traditional Chinese drug research were discussed in details. The results were of important value in accelerating the transformation of traditional Chinese medicine compound, and constructing the new drug innovation and review system for traditional Chinese medicine.

Citing Articles

Assessment of the potential value of combining western medicine therapies with traditional chinese medicine in the treatment of COVID-19: Mechanistic perspectives.

Zeng Z Technol Health Care. 2023; 31(S1):169-184.

PMID: 37038790 PMC: 10200170. DOI: 10.3233/THC-236015.


Reflections on treatment of COVID-19 with traditional Chinese medicine.

Luo H, Gao Y, Zou J, Zhang S, Chen H, Liu Q Chin Med. 2020; 15:94.

PMID: 32905189 PMC: 7468089. DOI: 10.1186/s13020-020-00375-1.